Enhancing Suicide Prevention in Emergency Care via Telehealth (R01 Clinical Trial Optional)

The summary for the Enhancing Suicide Prevention in Emergency Care via Telehealth (R01 Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Enhancing Suicide Prevention in Emergency Care via Telehealth (R01 Clinical Trial Optional): The purpose of this funding opportunity announcement is to solicit research to develop, optimize and test mental health telehealth methods (i.e., without involving in-person interaction between a mental health clinician and the patient) to help evaluate and treat emergency department (ED) patients with suicide risk, compared to usual care of such patients in emergency departments without adequate on-site mental health specialty consultation. Primary research questions include if the use of telehealth methods affects the proportion of ED patients who are (1) considered at imminent risk for suicide, (2) boarded in the ED due to suicide risk, and (3) require hospitalization for suicide risk; (4) whether use of telehealth methods affects the rate of within-encounter provision of evidence-based suicide prevention interventions; and whether use of telehealth methods affects (5) the rates of suicide ideation, attempts and deaths, and (6) health care use and costs, in the year after an index ED visit in which a patient was identified with suicide risk. To inform future implementation of telehealth enabled suicide prevention practices in the ED, qualitative data on patient and provider views of telehealth provision of suicide prevention practices (feasibility and acceptability of clinical decision making; clinical workflows; ease of use of technology) are sought.

Federal Grant Title:	Enhancing Suicide Prevention in Emergency Care via Telehealth (R01 Clinical Trial Optional)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-MH-20-226
Type of Funding:	Grant
CFDA Numbers:	93.242
CFDA Descriptions:	Information not provided
Current Application Deadline:	October 15th, 2020
Original Application Deadline:	October 15th, 2020
Posted Date:	November 19th, 2019
Creation Date:	November 19th, 2019
Archive Date:	November 20th, 2020
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	November 19th, 2019

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-226.html
Grant Announcement Contact: NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Advancing Research on Empirically-Supported Interventions for Older Adults Living with Ser...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Re...; • Single Source: Accelerating Medicines Partnership Schizophrenia (AMP SCZ): Data Processing...; • Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowe...; • Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R4...; • Development of Biomarkers for Mental Health Research and Clinical Utilities (SBIR [R43/R44...; • Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44])
More Grants from the National Institutes of Health: • NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clini...; • NIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not All...; • Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Ad...; • Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial N...; • Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Ad...